We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AVTE market cap is 571.22M. The company's latest EPS is USD -2.7295 and P/E is -7.46.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -15.85M | -17.64M | -20.34M | -21.37M | -22.07M |
Net Income | -15.02M | -16.52M | -19.03M | -19.56M | -20.41M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.33M | -8.89M | -23.02M | -53.24M | -81.41M |
Net Income | -3.33M | -9.61M | -22.96M | -51.51M | -75.52M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 135.3M | 124.39M | 155.76M | 140.88M | 127.42M |
Total Liabilities | 8.56M | 11.3M | 13.83M | 15.15M | 17.96M |
Total Equity | 126.74M | 113.1M | 141.93M | 125.72M | 109.46M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 3.51M | 4.72M | 175.36M | 135.3M | 127.42M |
Total Liabilities | 657k | 1.77M | 2.95M | 8.56M | 17.96M |
Total Equity | -3.64M | -13.34M | 172.42M | 126.74M | 109.46M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -39.12M | -11.42M | -60.54M | -41.98M | -56.78M |
Investing | 6.93M | 15.38M | 19.36M | 6.23M | 11.88M |
Financing | 396k | 223k | 45.51M | 45.53M | 46M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -2.78M | -7.86M | -27.4M | -39.12M | -56.78M |
Investing | N/A | N/A | -113.43M | 6.93M | 11.88M |
Financing | 2.5M | 8.92M | 190.46M | 396k | 46M |
Market Cap | 571.22M |
Price to Earnings Ratio | -7.46 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 23.98 |
Price to Book Ratio | 5.15 |
Dividend Yield | - |
Shares Outstanding | 27.67M |
Average Volume (1 week) | 352.98k |
Average Volume (1 Month) | 256.59k |
52 Week Change | 26.66% |
52 Week High | 32.415 |
52 Week Low | 9.41 |
Spread (Intraday) | 0.06 (0.29%) |
Company Name | Aerovate Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aerovatetx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions